Cargando…
Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids
Aim to evaluate the efficacy and safety of glucocorticoid monotherapy vs combination therapy of cyclophosphamide (CYC) for IgG4 related disease (IgG4-RD). 102 newly diagnosed IgG4-RD patients were enrolled and assigned to 2 groups: Group I was prednisone monotherapy (0.5–1.0 mg/kg.d, tapered gradual...
Autores principales: | Yunyun, Fei, Yu, Chen, Panpan, Zhang, Hua, Chen, Di, Wu, Lidan, Zhao, Linyi, Peng, Li, Wang, Qingjun, Wu, Xuan, Zhang, Yan, Zhao, Xiaofeng, Zeng, Fengchun, Zhang, Wen, Zhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522435/ https://www.ncbi.nlm.nih.gov/pubmed/28733656 http://dx.doi.org/10.1038/s41598-017-06520-5 |
Ejemplares similares
-
Comparison of the Effects of Cyclophosphamide and Mycophenolate Mofetil Treatment Against Immunoglobulin G4-Related Disease: A Retrospective Cohort Study
por: Luo, Xuan, et al.
Publicado: (2020) -
Intrathoracic Involvements of Immunoglobulin G4-Related Sclerosing Disease
por: Fei, Yunyun, et al.
Publicado: (2015) -
Failure of remission induction by glucocorticoids alone or in combination with immunosuppressive agents in IgG4-related disease: a prospective study of 215 patients
por: Wang, Liwen, et al.
Publicado: (2018) -
Malignancy and IgG4-related disease: the incidence, related factors and prognosis from a prospective cohort study in China
por: Tang, Hanqi, et al.
Publicado: (2020) -
IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease
por: Peng, Linyi, et al.
Publicado: (2020)